A phase I/II trial of trifluridine/tipiracil in combination with irinotecan in patients with advanced gastric cancer refractory to fluoropyrimidine, platinum, and taxane.
作者： Yusuke Amanuma , Tomohiro Nishina , Naoki Takahashi , Takako Eguchi Nakajima , Keiko Minashi
DOI: 10.1200/JCO.2021.39.3_SUPPL.210
关键词:
摘要: 210Background: Trifluridine/tipiracil (FTD/TPI) or irinotecan is a treatment option in the heavily pretreated patients with advanced gastric cancer (AGC) limited efficacy. Thus, we investi...
sci-hub.st 参考文章(0)